Holen Sie sich die Stockscreener-App
10.99
0.32%
-0.0356
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WBA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.03
Offen:
$11.01
24-Stunden-Volumen:
2.17M
Relative Volume:
0.11
Marktkapitalisierung:
$9.42B
Einnahmen:
$147.66B
Nettoeinkommen (Verlust:
$-8.64B
KGV:
-1.0983
EPS:
-10.01
Netto-Cashflow:
$-363.00M
1W Leistung:
+0.96%
1M Leistung:
-1.12%
6M Leistung:
+18.74%
1J Leistung:
-37.53%
1-Tages-Spanne:
$10.95
$11.02
1-Wochen-Bereich:
$10.80
$11.08
52-Wochen-Spanne:
$8.08
$18.83
Walgreens Boots Alliance Inc Stock (WBA) Company Profile
Firmenname
Walgreens Boots Alliance Inc
Sektor
Branche
Telefon
(847) 315-2500
Adresse
108 WILMOT ROAD, DEERFIELD, IL
Vergleichen Sie WBA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WBA
Walgreens Boots Alliance Inc
|
10.99 | 9.42B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
2.40 | 186.97M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
4.23 | 170.90M | 0 | 0 | 0 | 0.00 |
|
PETS
Petmed Express Inc
|
3.48 | 63.83M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd
|
0.9776 | 9.97M | 0 | 0 | 0 | 0.00 |
Walgreens Boots Alliance Inc Stock (WBA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-20 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-12-22 | Eingeleitet | HSBC Securities | Hold |
| 2023-10-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-07-03 | Bestätigt | Morgan Stanley | Underweight |
| 2023-06-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Eingeleitet | Loop Capital | Buy |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Underweight |
| 2022-11-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-11-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-03-25 | Bestätigt | Deutsche Bank | Hold |
| 2021-01-11 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-01-11 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-04-06 | Hochstufung | UBS | Sell → Neutral |
| 2020-04-03 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2019-12-11 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-10-30 | Bestätigt | Pivotal Research Group | Hold |
| 2019-10-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Sell |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-04-03 | Herabstufung | Loop Capital | Buy → Hold |
| 2019-04-03 | Bestätigt | Pivotal Research Group | Hold |
| 2019-03-08 | Bestätigt | BofA/Merrill | Underperform |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2018-12-19 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-12-14 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-15 | Bestätigt | Pivotal Research Group | Hold |
| 2018-10-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2018-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-07-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-02 | Bestätigt | Pivotal Research Group | Hold |
| 2018-06-29 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Walgreens Boots Alliance Inc Aktie (WBA) Neueste Nachrichten
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025 - marketscreener.com
BrightSpring Health Services Inc [BTSG] Shares Rise 1.72 % on Thursday - knoxdaily.com
(WBA) Technical Data - news.stocktradersdaily.com
Walgreens to help cover tuition for techs going to pharmacy school - Crain's Chicago Business
Walgreens is on the Hook For up to $350 Million After Filling Illegal Prescriptions - Cars 108
Walgreens leader in Texas sees increased demand for measles vaccine - Walgreens Boots Alliance
Walgreens reaches $300m deal over opioid prescriptions claims - Yahoo Finance
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline | WBA Stock News - GuruFocus
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline - Business Wire
Jim Cramer on Walgreens (WBA): “Clock’s Ticking on That One” - Insider Monkey
Understanding the Risks of Investing in Walgreens Boots Alliance Inc (WBA) - knoxdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders - PR Newswire
In time for Earth Day, a new pilot aims to further reduce waste in our supply chain - Walgreens Boots Alliance
Walgreens To Pay Up To $350 Mln For Opioid Settlement - RTTNews
Walgreens to settle invalid prescriptions case for $300 million - The Arkansas Democrat-Gazette
Walgreens (WBA) Settles Opioid Prescription Allegations for $350M - GuruFocus
Walgreens to pay $350M in U.S. opioid settlement (WBA:NASDAQ) - Seeking Alpha
Walgreens (WBA) Agrees to $3.5 Billion Settlement Over Opioid Prescriptions - GuruFocus
Walgreens agrees to pay up to $350 million to U.S. government in opioid settlement - MarketWatch
Walgreens to pay $300 million to settle claims it illegally filled invalid opioid prescriptions - KPAX News
Deerfield-based Walgreens to pay $300 million to settle federal allegations of unlawfully filling opioid scripts - Lake and McHenry County Scanner
Long-Term Investors in shares of Walgreens Boots Alliance, Inc. - openPR.com
WBA Stock Quote Price and Forecast - CNN
Sector Update: Health Care - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Walgreens settlement: Pharmacy chain agrees to pay up to $350M for illegally filling unlawful opioid prescriptions - ABC7 Chicago
Walgreens Must Pay Hefty Fine In Opioid CaseWalgreens Boots Alliance (NASDAQ:WBA) - Benzinga
Walgreens to pay $300 million in US opioid settlement - Reuters
Walgreens paying up to $350M as it tries to close the book on opioid lawsuits - Crain's Chicago Business
Walgreens Boots Alliance (WBA) Settles Opioid Prescription Allegations for $300 Million - GuruFocus
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says By Reuters - Investing.com
Walgreens to Pay Up to $350 Million to Settle Claims It Played a Role in the US Opioid Crisis - marketscreener.com
6.5M Pounds of Medications Safely Disposed: Walgreens Leads National Drug Take Back Day 2025 - Stock Titan
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says - NewsBreak: Local News & Alerts
Boots Workers Worry About Sycamore Cost Cuts - The Business of Fashion
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day this Saturday - Walgreens Boots Alliance
Townsquare Capital LLC Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Short Interest in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Decreases By 20.2% - Defense World
Walgreens To Pay DOJ $300M Over Invalid Prescriptions - Law360
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules - GuruFocus
Walgreens settles opioid litigation for $300 million - Investing.com
Hanes' CLO Resigns For 'Another Business Opportunity' - Law360
Investors | Global Leaders in Retail Pharmacy | WBA - Walgreens Boots Alliance
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions - TradingView
6 ways your pharmacist can support your health and wellness - Walgreens Boots Alliance
Wells Fargo & Company MN Has $10.09 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Franklin Resources Inc. Decreases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Arrowhead Pharma Taps Walgreens Finance Chief to Lead Commercial Stage Transition - Stock Titan
Walgreens: Acquisition Is The Best-Case Scenario For The Company - Seeking Alpha
Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says - Healthcare Brew
More Walgreens Locations Set to Shut Down in Connecticut This May - NewsBreak: Local News & Alerts
Finanzdaten der Walgreens Boots Alliance Inc-Aktie (WBA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
4.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):